Clinical Goals and Barriers to Effective Psoriasis Care

Autor: Colin Theng, Marc Bourcier, Craig L. Leonardi, Bruce Strober, Lars Iversen, Jashin J. Wu, Ronald Vender, Johann E. Gudjonsson, April W. Armstrong, Alexa B. Kimball, Charles N. Ellis, Arnon D. Cohen, Andrew Yule Finlay, Alice B. Gottlieb, Charles Lynde, Claudia de la Cruz, Andre V. E. de Carvalho, Caitriona Ryan, Edgardo Chouela, C. Elise Kleyn, Joelle M. van der Walt, Fernando Valenzuela, Helen S. Young
Jazyk: angličtina
Rok vydání: 2018
Předmět:
Zdroj: Dermatology and Therapy, Vol 9, Iss 1, Pp 5-18 (2018)
Dermatology and Therapy
Strober, B E, van der Walt, J M, Armstrong, A W, Bourcier, M, Carvalho, A V E, Chouela, E, Cohen, A D, de la Cruz, C, Ellis, C N, Finlay, A Y, Gottlieb, A B, Gudjonsson, J E, Iversen, L, Kleyn, C E, Leonardi, C L, Lynde, C W, Ryan, C, Theng, C T, Valenzuela, F, Vender, R, Wu, J J, Young, H S & Kimball, A B 2019, ' Clinical Goals and Barriers to Effective Psoriasis Care ', Dermatology and therapy, vol. 9, no. 1, pp. 5-18 . https://doi.org/10.1007/s13555-018-0279-5
Strober, B E, van der Walt, J M, Armstrong, A W, Bourcier, M, Carvalho, A V E, Chouela, E, Cohen, A D, de la Cruz, C, Ellis, C N, Finlay, A Y, Gottlieb, A B, Gudjonsson, J E, Iversen, L, Kleyn, C E, Leonardi, C L, Lynde, C W, Ryan, C, Theng, C T, Valenzuela, F, Vender, R, Wu, J J, Young, H S & Kimball, A B 2019, ' Clinical Goals and Barriers to Effective Psoriasis Care ', Dermatology and Therapy, vol. 9, no. 1, pp. 5-18 . https://doi.org/10.1007/s13555-018-0279-5
ISSN: 2190-9172
2193-8210
DOI: 10.1007/s13555-018-0279-5
Popis: Engaging global key opinion leaders, the International Psoriasis Council (IPC) held a day-long roundtable discussion with the primary purpose to discuss the treatment goals of psoriasis patients and worldwide barriers to optimal care. Setting clear expectations might ultimately encourage undertreated psoriasis patients to seek care in an era in which great gains in therapeutic efficacy have been achieved. Here, we discuss the option for early treatment of all categories of psoriasis to alleviate disease impact while emphasizing the need for more focused attention for psoriasis patients with mild and moderate forms of this autoimmune disease. In addition, we encourage policy changes to keep pace with the innovative therapies and clinical science and highlight the demand for greater understanding of treatment barriers in resource-poor countries.
Databáze: OpenAIRE